BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2160427)

  • 1. Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides.
    Head S; Ramotar K; Lingwood C
    Infect Immun; 1990 Jun; 58(6):1532-7. PubMed ID: 2160427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
    Waddell T; Head S; Petric M; Cohen A; Lingwood C
    Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globotetraosylceramide is recognized by the pig edema disease toxin.
    DeGrandis S; Law H; Brunton J; Gyles C; Lingwood CA
    J Biol Chem; 1989 Jul; 264(21):12520-5. PubMed ID: 2663859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verotoxin receptor glycolipid in human renal tissue.
    Boyd B; Lingwood C
    Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
    Kiarash A; Boyd B; Lingwood CA
    J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
    Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
    J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
    Ashkenazi S; Cleary TG
    J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures.
    Yiu SC; Lingwood CA
    Anal Biochem; 1992 Apr; 202(1):188-92. PubMed ID: 1621981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
    Nyholm PG; Brunton JL; Lingwood CA
    Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
    Lingwood CA; Yiu SK
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit.
    Tyrrell GJ; Ramotar K; Toye B; Boyd B; Lingwood CA; Brunton JL
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):524-8. PubMed ID: 1731324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes.
    Mobassaleh M; Gross SK; McCluer RH; Donohue-Rolfe A; Keusch GT
    Gastroenterology; 1989 Aug; 97(2):384-91. PubMed ID: 2663611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
    Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
    Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.
    Keusch GT; Jacewicz M; Acheson DW; Donohue-Rolfe A; Kane AV; McCluer RH
    Infect Immun; 1995 Mar; 63(3):1138-41. PubMed ID: 7868240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
    Picking WD; McCann JA; Nutikka A; Lingwood CA
    Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
    Devenish J; Gyles C; LaMarre J
    Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.
    Sawada R; Hotta H; Chung YS; Sowa M; Tai T; Yano I
    Jpn J Cancer Res; 1998 Feb; 89(2):167-76. PubMed ID: 9548444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.